"Amethyst Group Expands into Portugal with Acquisition of Júlio Teixeira in Nuclear Medicine"

"CMS Portugal advised the Amethyst Group on its first investment in Portugal, acquiring Júlio Teixeira, a company specializing in nuclear medicine and radiotherapy. Financial advice was provided by Banco Finantia, while the seller received guidance from Morais Leitão and PwC. The transaction involved key personnel from both CMS Portugal and Morais Leitão."

In a recent transaction, CMS Portugal and Morais Leitão provided legal assistance, with CMS Portugal advising the Amethyst Group on its acquisition of Júlio Teixeira, while Morais Leitão represented the seller. The Amethyst Group, an international player in the healthcare sector, made its first investment in Portugal by acquiring Júlio Teixeira, a Portuguese company specializing in nuclear medicine and radiotherapy, known for its innovation and clinical excellence. Financial advice for the transaction was provided by Banco Finantia, while the seller also received financial guidance from PwC. The legal teams involved included CMS Portugal's corporate M&A team, led by partner Francisco Xavier de Almeida, with managing associate David Apolónia and associate Francisca Pereira da Cruz participating. On the side of Morais Leitão, the transaction was led by partners Jorge Simões Cortez and Constança Carrington, with associate Tiago Ribeiro dos Santos also contributing from the corporate M&A department.

"Amethyst Group Expands into Portugal with Acquisition of Júlio Teixeira in Nuclear Medicine"

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads